Related Experiment Video
Updated: Feb 10, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
Christoph Heining1,2,3,4, Peter Horak5,6,7, Sebastian Uhrig7,8,9
1Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Dresden, Dresden, Germany.
Identifying gene fusions in young adults with pancreatic cancer (PDAC) revealed new treatment targets. Targeting NRG1 rearrangements with ERBB inhibitors led to remission in patients with KRAS wild-type tumors.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with limited therapeutic options.
- Molecularly targeted therapies for PDAC are lacking, particularly for younger patients.
- Precision oncology approaches are needed to identify actionable genomic alterations.
Purpose of the Study:
- To identify clinically actionable genomic alterations in young adults with PDAC.
- To investigate the role of gene fusions in PDAC development and progression.
- To evaluate the efficacy of targeted therapies against identified genomic alterations.
Main Methods:
- Whole-genome and transcriptome sequencing of 17 PDAC patients.
- Molecular characterization of tumors within a precision oncology program.
- Pharmacologic inhibition of identified aberrant signaling pathways.
Main Results:
- All KRAS wild-type (KRASWT) PDAC tumors (4/17) harbored actionable gene fusions.
- Recurrent NRG1 rearrangements were identified as drivers of PDAC via ERBB signaling.
- ERBB inhibition led to clinical improvement and remission of liver metastases in 2 patients with NRG1-rearranged tumors resistant to standard treatment.
Conclusions:
- Systematic screening for oncogenic fusion genes in KRASWT PDAC can improve therapeutic outcomes.
- NRG1 fusions represent a novel class of disease-driving events in PDAC.
- Targeting ERBB signaling offers a promising therapeutic strategy for a subset of PDAC patients.
Related Concept Videos
Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
Tagging and Fusion Proteins
SNAREs and Membrane Fusion
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

